467 related articles for article (PubMed ID: 27803741)
1. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care.
De Rosa M; Rega D; Costabile V; Duraturo F; Niglio A; Izzo P; Pace U; Delrio P
Therap Adv Gastroenterol; 2016 Nov; 9(6):861-886. PubMed ID: 27803741
[TBL] [Abstract][Full Text] [Related]
2. Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy.
Turano M; Delrio P; Rega D; Cammarota F; Polverino A; Duraturo F; Izzo P; De Rosa M
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817090
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009).
Zinser-Sierra JW; Rodríguez-Ramírez S; Villalobos-Valencia R; Ramírez-Márquez M
Drugs R D; 2011; 11(2):101-11. PubMed ID: 21679003
[TBL] [Abstract][Full Text] [Related]
5. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
6. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of metastatic colorectal cancer in the era of precision medicine.
Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
[TBL] [Abstract][Full Text] [Related]
8. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive factors in colorectal cancer.
Bolocan A; Ion D; Ciocan DN; Paduraru DN
Chirurgia (Bucur); 2012; 107(5):555-63. PubMed ID: 23116828
[TBL] [Abstract][Full Text] [Related]
10. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
11. Colorectal cancer: from prevention to personalized medicine.
Binefa G; Rodríguez-Moranta F; Teule A; Medina-Hayas M
World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
[TBL] [Abstract][Full Text] [Related]
12. Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.
Koulis C; Yap R; Engel R; Jardé T; Wilkins S; Solon G; Shapiro JD; Abud H; McMurrick P
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231042
[TBL] [Abstract][Full Text] [Related]
13. Current and future biomarkers in the treatment of colorectal cancer.
Cuyle PJ; Prenen H
Acta Clin Belg; 2017 Apr; 72(2):103-115. PubMed ID: 27917697
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive biomarkers for detection and staging of colorectal cancer.
Booth RA
Cancer Lett; 2007 Apr; 249(1):87-96. PubMed ID: 17275174
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
Cao Q; Tian Y; Deng Z; Yang F; Chen E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
Ogino S; Lochhead P; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT
Oncogene; 2014 Jun; 33(23):2949-55. PubMed ID: 23792451
[TBL] [Abstract][Full Text] [Related]
19. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]